NEOTHERAPEUTICS (NEOT) (NEOTW) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : NEOTHERAPEUTICS (NEOT) (NEOTW)

NEOT 1.919

+4.3%

Jan 17 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: john jansen who wrote (681)	6/13/1999 2:29:00 PM
From: Marty	Read Replies (1) of 705

It is kind of a dicey situation for companies with drugs in development. The more information they release, the more competing companies get to use to catch up with them. Other drug companies can deduce how far Neotherapeutics has progressed, the research directions they may have taken (or discarded), and any number of other things that you would not normally want a competitor to have. Although NEOT is at least a year ahead of anyone else with this particular approach and they have patent protection on this family of drugs, there are formidable competitors in the field who would love know the same data the stockholders would love to know. They say that in this field the ones with the most say and publish the least and the ones with the least say the most. As much as I would like to know the detailed test results, I now appreciate a lot more the wisdom of withholding it. Even so, a little reassurance from time to time that things are still going great with whatever can be released is certainly welcome.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next